Diphtheria and tetanus nasal vaccine - Chiron/West Pharmaceutical
Alternative Names: Nasal diphtheria and tetanus vaccine - Chiron/West PharmaceuticalsLatest Information Update: 04 Feb 2008
At a glance
- Originator Novartis; West Pharmaceutical Services
- Class Bacterial vaccines; Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diphtheria; Tetanus
Most Recent Events
- 20 Apr 2006 Chiron Corporation has been acquired and merged into Novartis
- 31 Dec 2003 Phase-I clinical trials in Diphtheria in USA (Intranasal)
- 31 Dec 2003 Phase-I clinical trials in Tetanus in USA (Intranasal)